ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,769Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 49

$641K Total Retail Price of All Prescriptions

Rank: 3 out of 49

460 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wyoming
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 460 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 9,440 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wyoming
SIMVASTATIN 587 535 1 2
LEVOTHYROXINE SODIUM 518 475 2 1
AMLODIPINE BESYLATE 344 326 3 6
OMEPRAZOLE 266 220 4 4
LISINOPRIL 248 231 5 3
METFORMIN HCL 244 169 6 10
HYDROCHLOROTHIAZIDE 218 206 7 12
SPIRONOLACTONE 197 170 8 26
METOPROLOL TARTRATE 194 170 9 11
MELOXICAM 188 152 10 31
METOPROLOL SUCCINATE 177 173 11 16
ALLOPURINOL 153 144 12 21
LOSARTAN POTASSIUM 151 139 13 14
ATORVASTATIN CALCIUM 149 149 14 13
BUMETANIDE 145 133 15 42
PREDNISONE 143 126 16 30
TRAMADOL HCL 137 117 17 29
FUROSEMIDE 136 89 18 5
ATENOLOL 127 111 19 17
SYNTHROID 124 115 20 45
WARFARIN SODIUM 124 96 20 8
TAMSULOSIN HCL 123 114 22 25
PRAVASTATIN SODIUM 119 114 23 20
GABAPENTIN 115 92 24 15
HYDROCODONE-ACETAMINOPHEN 111 91 S3 25 7
SPIRONOLACTONE-HCTZ 110 100 26 69
ZOLPIDEM TARTRATE 104 104 27 19
POTASSIUM CHLORIDE 102 71 28 9
SERTRALINE HCL 98 93 29 22
PANTOPRAZOLE SODIUM 97 78 30 32
BENICAR 92 92 31 99
ALENDRONATE SODIUM 88 88 32 36
CELEBREX 88 76 32 57
CRESTOR 81 67 34 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 78 35 34
DIOVAN HCT 79 79 35 76
RAMIPRIL 77 73 37 79
SINGULAIR 70 59 38 70
NEXIUM 68 51 39 27
DEXILANT 67 66 40 67
CLONIDINE HCL 64 49 41 83
DONEPEZIL HCL 63 63 42 24
AZITHROMYCIN 62 56 43 47
PRAMIPEXOLE DIHYDROCHLORIDE 61 61 44 113
ADVAIR DISKUS 61 57 44 28
DIGOXIN 60 60 46 39
AMITRIPTYLINE HCL 60 60 R 46 56
GLIPIZIDE 59 48 48 73
DIOVAN 57 57 49 49
BYSTOLIC 55 55 50 61
SPIRIVA 55 49 50 37
METHOTREXATE 54 47 52 119
CYCLOBENZAPRINE HCL 53 38 R 53 92
EXELON 53 53 53 108
NAMENDA 53 53 53 41
MULTAQ 52 36 56 164
CIPROFLOXACIN HCL 50 46 57 76
GLIMEPIRIDE 50 50 57 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.